Updated:
Cadence Healthcare Ventures
Cadence Healthcare Ventures invests in early-stage healthcare startups from multiple offices.
Cadence Healthcare Ventures
Cadence is a MedTech-focused venture capital firm partnering with visionary teams to build acquisition-ready companies. From concept to commercialization, we engineer outcomes that matter - for patients, acquirers, and investors. We don’t just invest. We build. With two decades inside the innovation engines of healthcare, Founder & General Partner Chris Kaster has backed 60+ MedTech companies, led $1B+ in investments, and is trusted by founders, favored by strategics, and fluent in the nuance of MedTech exits. What sets Cadence apart: - Built for the buyout. Every company is engineered with acquirer priorities in mind. - Unrivaled access. Proprietary deal flow through board seats, operator networks, and deep strategic ties. - Hands-on partnership. Guiding teams through clinical, regulatory, and commercial milestones with precision. - AI & robotics focus. Backing the technologies that are redefining precision, efficiency, and outcomes. - Advisor edge. A best-in-class network of industry veterans, operators, and strategics fueling every decision.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Additional offices
Beverly Hills · Morristown · Paris · San Francisco · Los Angeles · Ross · London
Principals
Chris Kaster
Founder and Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Cadence Healthcare Ventures?
Chris Kaster serves as Founder and Managing Partner.
Does Cadence Healthcare Ventures participate in fund commitments or only direct deals?
The firm focuses on direct investments in early-stage startups.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: